• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.

  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Case Studies

Get inspired by research done by our scientists, partners, and customers around the globe. Select your topic of interest, and learn more.

 

3D intestine-on-a-chip model to study IBD
Together with Philip Morris International (PMI) we developed a 3D in vitro intestinal model consisting of epithelial and immune competent cells to study the hallmarks of IBD.
More information
3D immune cell migration towards a tumor microenvironment
We developed a 3D immune cell migration model to better understand the behavior of T cells in a tumor microenvironment.
More information
Antibody transcytosis across the blood-brain barrier (BBB)

We developed a unique 3D and membrane-free BBB-on-a-chip model compromising human brain endothelial cells, astrocytes, and pericytes. The model allows studying barrier function and antibody transcytosis in high-throughput.

More information
3D pancreas model to capture intratumoral pressure
Together with Leiden Academic Centre for Drug Research (LACDR), we developed a 3D microfluidic interstitial flow model to capture the intratumoral pressure in PDAC.
More information
3D glomerular filtration barrier model
Researchers from Children’s Hospital Los Angeles (CHLA) developed a glomerulus-on-a-chip model to recapitulate the human glomerular filtration barrier. The model is composed of human podocytes and human glomerular endothelial cells.
More information
Robust angiogenesis inhibition assay
Together with researchers from LUMC, Leiden University, and Ncardia, we developed a phenotypic angiogenesis inhibition assay including endothelial cells (ECs) from induced pluripotent stem cells (iPSC).
More information

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all